$1.21
0.054.31%
Pre-Market: 5:44 PM EDT
15 minutes delayed
Gain Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Gain Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GANX | Gain Therapeutics | -$0.62 | -$0.20 | — | — | $0.00 | $400.00K | — | — | 08/08/2024 | Get Alert |
GANX | Gain Therapeutics | -$0.43 | -$0.29 | -$0.22 | 24.14% | $55.18K | $30.00K | $0.00 | -100.00% | 05/14/2024 | Get Alert |
GANX | Gain Therapeutics | -$0.39 | -$0.32 | -$0.29 | 9.38% | $0.00 | $320.00K | $0.00 | -100.00% | 03/26/2024 | Get Alert |
GANX | Gain Therapeutics | -$0.38 | -$0.45 | -$0.37 | 17.78% | $0.00 | — | $0.00 | — | 11/14/2023 | Get Alert |
GANX | Gain Therapeutics | -$0.43 | -$0.31 | -$0.62 | -100.00% | $95.10K | $1.01M | $0.00 | -100.00% | 08/10/2023 | Get Alert |
GANX | Gain Therapeutics | -$0.28 | — | -$0.43 | — | $45.00K | — | $55.18K | — | 05/12/2023 | Get Alert |
GANX | Gain Therapeutics | -$0.26 | -$0.38 | -$0.39 | -2.63% | $43.21K | $10.00K | $0.00 | -100.00% | 03/23/2023 | Get Alert |
GANX | Gain Therapeutics | -$0.39 | -$0.46 | -$0.38 | 17.39% | $27.34M | $60.00K | $0.00 | -100.00% | 11/10/2022 | Get Alert |
GANX | Gain Therapeutics | -$0.30 | -$0.31 | -$0.43 | -38.71% | $89.71M | $30.00K | $95.10K | 217.01% | 08/08/2022 | Get Alert |
GANX | Gain Therapeutics | -$0.50 | -$0.37 | -$0.28 | 24.32% | $5.27K | $40.00K | $45.00K | 12.50% | 05/16/2022 | Get Alert |
GANX | Gain Therapeutics | -$0.53 | -$0.49 | -$0.26 | 46.94% | $9.14K | $50.00K | $43.21K | -13.58% | 03/24/2022 | Get Alert |
GANX | Gain Therapeutics | -$0.25 | -$0.36 | -$0.39 | -8.33% | $6.70K | $10.00K | $27.34K | 173.45% | 11/12/2021 | Get Alert |
GANX | Gain Therapeutics | -$0.27 | -$0.30 | -$0.30 | 0.00% | — | — | $89.71K | — | 08/11/2021 | Get Alert |
GANX | Gain Therapeutics | -$0.29 | -$0.19 | -$0.50 | -163.16% | $6.67M | — | $5.27K | — | 05/10/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-0.22 | $-0.29 | 24.1 % |
Dec 2023 | 2024-03-26 | $-0.29 | $-0.32 | 9.38 % |
Sep 2023 | 2023-11-14 | $-0.37 | $-0.45 | 17.8 % |
Jun 2023 | 2023-08-10 | $-0.62 | $-0.31 | -100.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $0 | $30.00K | -100.0 % |
Dec 2023 | 2024-03-26 | $0 | $320.00K | -100.0 % |
Jun 2023 | 2023-08-10 | $0 | $1.01M | -100.0 % |
Dec 2022 | 2023-03-23 | $0 | $10.00K | -100.0 % |
Gain Therapeutics (GANX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
The Actual EPS was $-0.22, which beat the estimate of $-0.29.
The Actual Revenue was $0K, which missed the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.